Physician profile
Jared T Scott
NPI 1497976633
$10,361.41
in general payments reported to CMS, 2019-2025
14 companies · $322 in 2025
The $322 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,861 · 2020: $3,058 · 2021: $497 · 2022: $2,254 · 2023: $621 · 2024: $749 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,608.57 | 2019-2020 | |
| Medtronic, INC. | $1,725.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Abbott Laboratories | $1,574.56 | 2019-2023 | Proclaim |
| Vertiflex, INC. | $1,240.79 | 2019 | |
| Relievant Medsystems, INC. | $967.04 | 2019 | |
| Nevro Corp. | $717.59 | 2020-2024 | Senza |
| Nalu Medical, INC. | $160.37 | 2022-2023 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $140.16 | 2023 | Superion Indirect Decompression System |
| Depuy Synthes Sales INC. | $104.11 | 2021-2022 | |
| Vertos Medical, INC. | $43.93 | 2019 | |
| Spr Therapeutics, INC | $38.96 | 2022-2024 | Sprint Pns System |
| Innovation Technologies INC | $15.90 | 2021 | |
| Zyla Life Sciences, INC. | $12.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.